Literature DB >> 13948620

Mechanism of the initial adrenergic effects of bretylium and guanethidine.

S D GOKHALE, O D GULATI, V V KELKAR.   

Abstract

Treatment with phenoxybenzamine and dichloroisoprenaline prevented the rise of blood pressure, contraction of the nictitating membrane and increase in cardiac contractile force produced by intravenous injections of bretylium and guanethidine in anaesthetized or spinal cats. Treatment with cocaine, imipramine or reserpine reduced the sensitivity to bretylium and guanethidine of the spinal cat. In the spinal cat treated with reserpine, sensitivity to the drugs could be restored by an infusion of noradrenaline. Chlorpromazine also blocked the pressor and nictitating membrane responses to bretylium and guanethidine. The drug effects were unaltered 1 hr after bilateral adrenalectomy. During the intravenous infusion of noradrenaline into spinal cats the pressor responses to bretylium and guanethidine were increased, whilst those to adrenaline and to noradrenaline were decreased. Guanethidine (3 to 5 mg/kg) injected intravenously into the cat caused a sudden relaxation of the rat isolated stomach-strip bathed in blood. In seven similar experiments bretylium (3 to 5 mg/kg) relaxed the strip only once; in the other six experiments there was either no effect (four experiments) or an increase in the tone of the strip (two experiments). It is concluded that the initial adrenergic effects of bretylium and guanethidine are mediated, at least in part, through a release of catechol amines from stores in the effector organ.

Entities:  

Keywords:  BRETYLIUM COMPOUNDS; GUANETHIDINE; SYMPATHOMIMETICS

Mesh:

Substances:

Year:  1963        PMID: 13948620      PMCID: PMC1703630          DOI: 10.1111/j.1476-5381.1963.tb01475.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  32 in total

1.  Effect of drugs on the uptake and metabolism of H3-norepinephrine.

Authors:  G HERTING; J AXELROD; L G WHITBY
Journal:  J Pharmacol Exp Ther       Date:  1961-11       Impact factor: 4.030

2.  Modification of the effect of tyramine by various agents and procedures.

Authors:  U TRENDELENBURG
Journal:  J Pharmacol Exp Ther       Date:  1961-10       Impact factor: 4.030

3.  The effects of guanethidine on the adrenal medulla.

Authors:  W J ATHOS; B P McHUGH; S E FINEBERG; J G HILTON
Journal:  J Pharmacol Exp Ther       Date:  1962-08       Impact factor: 4.030

4.  [Effect of guanethidine on arterial pressure and on the uterus of the rat].

Authors:  A DRESSE; J C SODOYEZ
Journal:  C R Seances Soc Biol Fil       Date:  1960

5.  The effects of a new sympathetic blocking drug (bretylium) on cardiovascular control.

Authors:  D M AVIADO; A H DIL
Journal:  J Pharmacol Exp Ther       Date:  1960-07       Impact factor: 4.030

6.  The action of sympathomimetic amines in animals treated with reserpine.

Authors:  J H BURN; M J RAND
Journal:  J Physiol       Date:  1958-12-04       Impact factor: 5.182

7.  Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline.

Authors:  G HERTTING; J AXELROD; R W PATRICK
Journal:  Br J Pharmacol Chemother       Date:  1962-02

8.  Mechanism of action of guanethidine.

Authors:  K KADZIELAWA
Journal:  Br J Pharmacol Chemother       Date:  1962-08

9.  [2-Octahydro-1-azocinyl)-ethyl]-guanidine sulfate (CIBA 5864-SU), a new synthetic antithypertensive agents].

Authors:  R A MAXWELL; R P MULL; A J PLUMMER
Journal:  Experientia       Date:  1959-07-15

10.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  8 in total

1.  Pharmacokinetic and pharmacodynamic effects of UK-68,798, a new potential class III antiarrhythmic drug.

Authors:  M Sedgwick; H S Rasmussen; D Walker; S M Cobbe
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

2.  Modification of some actions of guanethidine by the acute administration of reserpine.

Authors:  S Guimarães; M Sottomayor; J Castro-Tavares
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

3.  The action of guanethidine on the adrenal medulla of the cat.

Authors:  S D Jaanus; E Miele; R P Rubin
Journal:  Br J Pharmacol Chemother       Date:  1968-07

4.  Pulmonary vasoconstriction provoked by brief lung inflation.

Authors:  H J Colebatch; R A Nadeau
Journal:  J Physiol       Date:  1965-08       Impact factor: 5.182

5.  The antiadrenaline activity of some phenothiazine derivatives.

Authors:  R A Webster
Journal:  Br J Pharmacol Chemother       Date:  1965-10

6.  Pharmacology of N-[2-(2,6-xylyloxy)ethyl]-guanidine sulphate; an adrenergic neurone blocking agent.

Authors:  D I Barron; I L Natoff; D K Vallance
Journal:  Br J Pharmacol Chemother       Date:  1965-10

7.  THE ADRENERGIC-NEURONE BLOCKING ACTION OF SOME COUMARAN COMPOUNDS.

Authors:  R FIELDEN; A M ROE; G L WILLEY
Journal:  Br J Pharmacol Chemother       Date:  1964-12

8.  AN INVESTIGATION OF THE ADRENERGIC BLOCKING ACTION OF CHLORPROMAZINE.

Authors:  S D GOKHALE; O D GULATI; H M PARIKH
Journal:  Br J Pharmacol Chemother       Date:  1964-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.